Kardigan, Inc. (KARD)
21.92
+2.32
(+11.84%)
USD |
NASDAQ |
Sep 02, 16:00
21.88
-0.04
(-0.18%)
After-Hours: 20:00
Kardigan Net Income (Quarterly) : -116.24M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -116.24M |
| March 31, 2026 | -56.07M |
| Date | Value |
|---|---|
| June 30, 2025 | -57.44M |
| March 31, 2025 | -18.02M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Johnson & Johnson | 5.534B |
| Bristol Myers Squibb Co. | 3.316B |
| Crinetics Pharmaceuticals, Inc. | -120.86M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 116.24M |
| EPS Diluted (Quarterly) | -1.244 |
| Enterprise Value | 1.465B |
| Earnings Yield | -12.39% |
| Normalized Earnings Yield | -10.76 |